However, enduring negative and cognitive symptoms of schizophrenia, resistant to DRD2 antagonist treatment, suggested that they might be due to a deficit in the prefrontal cortex (PFC) DA transmission at DRD1 [177,178,179,180]. The gene discussed is DRD2; the disease is schizophrenia.